Skip to main content

Table 4 Choice of NRT medication by product and short-term abstinence rates by type of NRT used; % (n)

From: Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services

Product All clients (n = 1810) NRT type 3–4 week CO-validated abstinence (n = 502)
Inhalator 10.2 (185) Inhalator 37.2 (67)
16 hour patch 19.4 (352) Patch 43.0 (535)
24 hour patch 51.7 (936)   
2 mg gum 1.5 (27) Gum 35.3 (30)
4 mg gum 3.3 (59)   
Nasal spray 2.5 (46) Nasal spray 38.6 (17)
1 mg lozenge1 .1 (2) Lozenge 42.7 (44)
2 mg lozenge1 1.3 (23)   
4 mg lozenge1 1.4 (25)   
Lozenge2 3.0 (55)   
Microtab 5.5 (99) Microtab 44.3 (43)
  1. 1 Service one only collected data on strength of lozenge. 2 Second service lozenge data